UspA1 and UspA2 antigens of moraxella catarrhalis
    1.
    发明申请
    UspA1 and UspA2 antigens of moraxella catarrhalis 失效
    UspA1和UspA2卡他莫拉菌素抗原

    公开(公告)号:US20030032772A1

    公开(公告)日:2003-02-13

    申请号:US09952267

    申请日:2001-09-12

    CPC classification number: C07K14/212 A61K39/00 C07K16/1217

    Abstract: The present invention discloses the existence of two novel proteins UspA1 and UspA2, and their respective genes uspA1 and uspA2. Each protein encompasses a region that is conserved between the two proteins and comprises an epitope that is recognized by the MAb 17C7. One or more than one of these species may aggregate to form the very high molecular weight form (i.e. greater than 200 kDa) of the UspA antigen. Compositions and both diagnostic and therapeutic methods for the treatment and study of M. catarrhalis are disclosed.

    Abstract translation: 本发明公开了两种新型蛋白质UspA1和UspA2及其各自的基因uspA1和uspA2的存在。 每个蛋白质包含在两种蛋白质之间保守的区域,并且包含由MAb 17C7识别的表位。 这些物质中的一种或多于一种可能聚集形成UspA抗原的非常高分子量形式(即大于200kDa)。 公开了组合物以及用于治疗和研究卡他莫拉菌的诊断和治疗方法。

    FUNCTIONALIZED POLYOLEFIN CAPILLARIES FOR OPEN TUBULAR ION CHROMATOGRAPHY

    公开(公告)号:US20210016266A1

    公开(公告)日:2021-01-21

    申请号:US17022304

    申请日:2020-09-16

    Abstract: Open tubular capillary columns for liquid and ion chromatography, based upon an ionically impermeable polyolefin capillary having a bore with a sulfonate-group- or amine-group-functionalized internal surface. The capillary columns may include a coating of ion exchanging nanoparticles electrostatically bound to the functionalized internal surface. The capillary columns may be made by exposing the interior surface to a sulfonating reagent comprising chlorosulfonic acid (CISO3H), preferably from 85 wt % to 95 wt % chlorosulfonic acid at a process temperature of 20 to 25° C. The interior surface may be subsequently exposed to an asymmetrical diamine to form a sulfonic mid-linkage to the diamine, i.e., to form a sulfonamide-linked, amine-group-functionalized internal surface. The coating may be provided by subsequently exposing the interior surface to an aqueous suspension of ion exchanging nanoparticles to electrostatically bond the ion exchanging nanoparticles to the functionalized internal surface.

    Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
    5.
    发明申请
    Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists 审中-公开
    使用整联蛋白拮抗剂治疗多发性骨髓瘤和骨髓瘤诱导的骨吸收的方法

    公开(公告)号:US20020041874A1

    公开(公告)日:2002-04-11

    申请号:US09943659

    申请日:2001-08-31

    Abstract: Antagonists of null4 integrin/null4 integrin ligand adhesion, which inhibit the biological effects of such adhesion are described and methods for their use are detailed. Such antagonists are useful in suppressing bone destruction associated with multiple myeloma. The homing of multiple myeloma cells to bone marrow and their null4 integrin-dependent release of bone-resorbing factors, resulting in bone destruction in patients with multiple myeloma, is inhibited.

    Abstract translation: 描述了抑制这种粘附的生物学作用的α4整联蛋白/α4整联蛋白配体粘附的拮抗剂,并详细说明了其使用方法。 这样的拮抗剂可用于抑制与多发性骨髓瘤相关的骨破坏。 多发性骨髓瘤细胞归巢到骨髓及其α4整联蛋白依赖性释放的骨吸收因子,导致多发性骨髓瘤患者骨质破坏。

Patent Agency Ranking